Welcome to the SkinCure Oncology Press Room. If you’re a journalist with an interest in skin cancer, its causes, prevention, or treatment and outcomes, you’ve come to the right place. In this section of our web site, you’ll find:
We’re in the business of providing medical professionals with the ability to offer image-guided superficial radiotherapy directly in their practices. Our passion, however, is for the patient – those who have been diagnosed with non-melanoma and seeking a highly-effective alternative to surgical intervention. With that is mind, we offer to qualified broadcasters and journalists access to all of the above, free of charge.
Working journalists are welcome to contact us:
Toll-free media hotline
Breaking news and after-hours
If you’re a dermatologist considering adding IG-SRT to your practice, contact:
Here are links to our most recent press releases:
For a full list of press releases click here.
Access our galleries for the latest images and videos related to SkinCure Oncology, non-melanoma skin cancer (basal cell carcinoma and squamous cell carcinoma), and Image-Guided Superficial Radiotherapy (IG-SRT). If you don’t see the picture or video you need, give us a call as we may have what you’re looking for in our offline archive.
Basal Cell Carcinoma
Squamous Cell Carcinoma
Before and After
Patient and Therapist
Logos and Marks
SkinCure Oncology partners with dermatology practices in more than 135 markets throughout the United States, providing non-melanoma skin cancer patients and keloid patients with a non-surgical alternative to Mohs Surgery. To date, more than 25,000 people with basal cell and squamous cell carcinomas have been successfully treated with Image-Guided Superficial Radiotherapy (IG-SRT).
Our subject matter experts are available without charge to qualified media outlets, journalists, authors and bloggers. Here are just some of the many topics we’re able to address:
Our subject matter experts include:
If you’re in need of a subject matter expert, contact us and we will connect you with a recognized authority. Subject matter experts are available for remote and, in some cases, in-studio interviews.
Call our toll-free media hotline at 866-215-0047.
With more than 5 million people a year seeking information on less-invasive skin cancer treatment options, IG-SRT is a growing topic of interest, making for exceptional features across blogs, podcasts, and news broadcasts. We’re happy to share these human-interest stories. Give us a call.
Access the latest white papers and studies on non-melanoma skin cancer and Image-Guided Superficial Radiotherapy.